Enforcement and administrative action

注意喚起 disclosure naming 武田薬品工業株式会社

武田薬品工業株式会社

The published name has not been matched to a verified Corporate Number. Check the identity before attributing this record to a company.

Action type
注意喚起
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
4 February 2015

Published details

The manufacturer and marketer repeatedly distributed 'Requests for Proper Use' to healthcare professionals and others, providing warnings and cautions.

Machine-translated from the Japanese disclosure. The original Japanese text is available below.

Sources and saved materials

Review the source list, printable report and available saved files.

Evidence pack ¥4,980tax included · one-time purchase

View contents and purchase options

Available PDFs, images and other files vary by record. Check the included materials before purchasing; a source URL does not guarantee an original file is included.

Purchase and download pages are currently in Japanese. Materials retain the original source language.

Official source URL recorded · Queued for preservation

Source links and saved files require purchase. Already purchased?

Action details

Industry (as published)
医薬品
Additional published details

The Ministry of Health, Labour and Welfare has revised the 'Precautions for Use' section of the package insert for the antiepileptic and bipolar disorder medication 'Lamictal Tablets' (attached document 1), based on reports of severe skin disorders leading to death. Additionally, it instructed manufacturers and marketers to promptly alert healthcare professionals through a 'Safety Information (Blue Letter)' (attached document 2).

Show original Japanese text

製造販売業者が、複数回にわたり「適正使用のお願い」を医療関係者等に配布し、注意喚起してきた。

Sources, saved materials and verification

Source verification

Public-source and preservation status

Publishing authority
Ministry of Health, Labour and Welfare
Official source URL
Recorded by RegBase
Entity match
Not confirmed; shown under the published name
Kiroku preservation
Queued for preservation

“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.

Open Sources and saved materials on this page to review the available pack contents.

About this action and law

This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.

Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.

Review the original Japanese source and determine relevance to your counterparty-risk workflow.

English translations are for reference. Verify important decisions against the original Japanese disclosure. View the Japanese page.